Erythropoietin attenuates intracerebral hemorrhage by diminishing matrix metalloproteinases and maintaining blood-brain barrier integrity in mice

Acta Neurochirurgica, Supplementum

Volumn , Issue 105, 2008, Pages 105-112

  Li, Y ^a   Ogle, M E ^a   Wallace IV, G C ^a   Lu, Z Y ^a   Yu, S P ^a,b   Wei, L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

anti inflammatory; blood brain barrier; Intracerebral hemorrhage; matrix metalloproteinase; neurovascular protection; recombinant human erythropoietin; tissue inhibitor of metalloproteinase

Indexed keywords

COLLAGEN TYPE 4; EVANS BLUE; GELATINASE A; GLIAL FIBRILLARY ACIDIC PROTEIN; MATRIX METALLOPROTEINASE; NEUROPROTECTIVE AGENT; RECOMBINANT ERYTHROPOIETIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; DIAGNOSTIC AGENT; MEMBRANE PROTEIN; OCCLUDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN WATER; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; IMMUNOFLUORESCENCE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; WATER CONTENT; WESTERN BLOTTING; ANIMAL; DISEASE MODEL; DRUG EFFECT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; TIME;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; CEREBRAL HEMORRHAGE; COLLAGEN TYPE IV; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN, RECOMBINANT; EVANS BLUE; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MICE; PERMEABILITY; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 85052609749     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-09469-3_22     Document Type: Article

References (23)

1. Andras IE, Deli MA, Veszelka S, Hayashi K, Hennig B, Toborek M (2007) The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells. J Cereb Blood Flow Metab 27:1431-1443
2. Bahcekapili N, Uzüm G, Gökkusu C, Kuru A, Ziylan YZ (2007) The relationship between erythropoietin pretreatment with bloodbrain barrier and lipid peroxidation after ischemia/reperfusion in rats. Life Sci 80:1245-1251
3. Cunningham LA, Wetzel M, Rosenberg GA (2005) Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50:329-339
4. Gasche Y, Soccal PM, Kanemitsu M, Copin JC (2006) Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 11:1289-1301
5. Genc S, Koroglu TF, Genc K (2004) Erythropoietin as a novel neuroprotectant. Restor Neurol Neurosci 22:105-119
6. Hawkins BT, Davis TP (2005) The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173-185
7. Lee ST, Chu K, Sinn DI, Jung KH, Kim EH, Kim SJ, Kim JM, Ko SY, Kim M, Roh JK (2006) Erythropoietin reduces perihematomal inflammation and cell death with eNOS and STAT3 activations in experimental intracerebral hemorrhage. J Neurochem 96:1728-1739
8. Li Y, Lu Z, Keogh CL, Yu SP, Wei L (2007) Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 27:1043-1054
9. Li Y, Lu ZY, Ogle M, Wei L (2007) Erythropoietin prevents bloodbrain barrier damage induced by focal cerebral ischemia in mice. Neurochem Res 32:2132-2141
10. Ma B, Zhang J (2006) Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage. Brain Res 1078:182-188
11. Martinez-Estrada OM, Rodriguez-Millán E, González-De Vicente E, Reina M, Vilaró S, Fabre M (2003) Erythropoietin protects the in vitro blood-brain barrier against VEGF-induced permeability. Eur J Neurosci 18:2538-2544
12. Nilupul Perera M, Ma HK, Arakawa S, Howells DW, Markus R, Rowe CC, Donnan GA (2006) Inflammation following stroke. J Clin Neurosci 13:1-8
13. Power C, Henry S, Del Bigio MR, Larsen PH, Corbett D, Imai Y, Yong VW, Peeling J (2003) Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases. Ann Neurol 53:731-742
14. Rosenberg GA (2002) Matrix metalloproteinases in neuroinflammation. Glia 39:279-291
15. Uzum G, Sarper Diler A, Bahcekapili N, Ziya Ziylan Y (2006) Erythropoietin prevents the increase in blood-brain barrier permeability during pentylentetrazol induced seizures. Life Sci 78:2571-2576
16. Villa P, Bigini P, Mennini T, Agnello D, Laragione T, Cagnotto A, Viviani B, Marinovich M, Cerami A, Coleman TR, Brines M, Ghezzi P (2003) Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 198:971-975
17. Wang J, Doré S (2007) Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 27:894-908
18. Wang J, Tsirka SE (2005) Neuroprotection by inhibition of matrix metalloproteinases in a mouse model of intracerebral haemorrhage. Brain 128:1622-1633
19. Wei L, Han BH, Li Y, Keogh CL, Holtzman DM, Yu SP (2006) Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats. J Pharmacol Exp Ther 317:109-116
20. Xue YQ, Zhao LR, Guo WP, Duan WM (2007) Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease. Neuroscience 146:1245-1258
21. Yang GY, Betz AL, Chenevert TL, Brunberg JA, Hoff JT (1994) Experimental intracerebral hemorrhage: relationship between brain edema, blood flow, and blood-brain barrier permeability in rats. J Neurosurg 81:93-102
22. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA (2007) Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab 27:697-709
23. Yatsiv I, Grigoriadis N, Simeonidou C, Stahel PF, Schmidt OI, Alexandrovitch AG, Tsenter J, Shohami E (2005) Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J 19:1701-1703